High dose intranasal desmopressin (DDAVP) therapy in type 2M von Willebrand disease (VWD): A prospective open label trial.

被引：0
|
作者：
Parameswaran, R
Di Paola, J
Miller-Rice, L
Greist, A
Shapiro, AD
机构：
[1] Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA
[2] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1783
引用
收藏
页码：507A / 507A
页数：1
相关论文
共 50 条
  • [1] A prospective comparision of intranasal (IN) and subcutaneous (SC) desmopressin (DDAVP) therapy in type 2M Von Willebrand disease (VWD).
    Parameswaran, Rekha
    Shapiro, Amy D.
    Di Paola, Jorge
    Winay, Jon
    Roberson, Chris
    Greist, Anne
    [J]. BLOOD, 2006, 108 (11) : 308A - 308A
  • [2] Biologic response to desmopressin (DDAVP) in 8 type 2 von Willebrand disease (vWD) patients
    Windyga, J.
    Bykowska, K.
    Baran, B.
    Stefanska, E.
    [J]. HAEMOPHILIA, 2008, 14 : 118 - 118
  • [3] Intranasal administration of desmopressin (DDAVP) for type 1 and type 2A von Willebrand disease
    Mohri, H
    Hashimoto, Y
    Yamazaki, E
    Kanamori, H
    Okubo, T
    [J]. HEMATOPATHOLOGY AND MOLECULAR HEMATOLOGY, 1998, 11 (02) : 109 - 115
  • [4] Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease
    Sharthkumar, A.
    Greist, A.
    Di Paola, J.
    Winay, J.
    Roberson, C.
    Heiman, M.
    Herbert, S.
    Parameswaran, R.
    Shapiro, A.
    [J]. HAEMOPHILIA, 2008, 14 (03) : 539 - 548
  • [5] DDAVP treatment in a child with von Willebrand disease type 2M
    C. Mauz-Körholz
    U. Budde
    D. Körholz
    U. Göbel
    [J]. European Journal of Pediatrics, 1999, 158 : S174 - S176
  • [6] DDAVP treatment in a child with von Willebrand disease type 2M
    Mauz-Körholz, C
    Budde, U
    Körholz, D
    Göbel, U
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1999, 158 (Suppl 3) : S174 - S176
  • [7] Identification of type 2M von Willebrand disease in previously diagnosed type 1 VWD
    Nitu-Whalley, IC
    Lee, CA
    Pasi, KJ
    Owens, D
    Riddell, A
    Jenkins, PV
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 27 - 27
  • [8] Racial disparity in the diagnosis of von willebrand disease (VWD) with particular reference to the diagnosis of type 2M VWD in African Americans
    Branchford, B. R.
    Kautza, B. C.
    Gill, J. C.
    Flood, V. H.
    Friedman, K. D.
    Lee, A.
    Morateck, P.
    Christopherson, P. A.
    Montgomery, R. R.
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 630 - 630
  • [9] DDAVP in patients with von Willebrand disease (VWD) type 2N and phenotype compatible with VWD type 2N.
    Casais, P
    Farias, CE
    Meschengieser, SS
    Carballo, GA
    Kempfer, AC
    Grosso, S
    Lazzari, MA
    [J]. BLOOD, 2001, 98 (11) : 80B - 80B
  • [10] How we diagnose 2M von Willebrand disease (VWD): Use of a strategic algorithmic approach to distinguish 2M VWD from other VWD types
    Favaloro, Emmanuel J.
    Mohammed, Soma
    Vong, Ronny
    Oliver, Susan
    Brennan, Yvonne
    Favaloro, James W.
    Curnow, Jennifer
    [J]. HAEMOPHILIA, 2021, 27 (01) : 137 - 148
12345